AFT Pharmaceuticals Limited (ASX:AFP)
Australia · Delayed Price · Currency is AUD 3.000
+0.030 (1.01%)
Jan 16, 2026, 3:13 PM AEST
AFT Pharmaceuticals Market Cap
AFT Pharmaceuticals has a market cap or net worth of 382.76 million as of January 16, 2026. Its market cap has increased by 38.39% in one year.
Market Cap
382.76M
Enterprise Value
407.40M
Revenue
207.12M
Ranking
n/a
PE Ratio
25.02
Stock Price
3.00
Market Cap Chart
Since December 22, 2015, AFT Pharmaceuticals's market cap has increased from 282.68M to 382.76M, an increase of 35.40%. That is a compound annual growth rate of 3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 334.14M | 9.29% |
| Dec 31, 2025 | 305.73M | 11.08% |
| Dec 31, 2024 | 275.23M | -19.28% |
| Dec 29, 2023 | 340.95M | -4.96% |
| Dec 29, 2022 | 358.75M | -18.74% |
| Dec 31, 2021 | 441.47M | -17.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.51B |
| Pro Medicus | 21.56B |
| Cochlear | 17.49B |
| Sonic Healthcare | 11.51B |
| Ramsay Health Care | 8.47B |
| Ansell | 4.84B |
| Telix Pharmaceuticals | 3.78B |
| Mesoblast | 3.48B |